Frequent occult hepatitis B virus infection in patients infected with human immunodeficiency virus type 1

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 2, 2003, Pages 92-98

  Santos, E A ^a   Yoshida, C F T ^a   Rolla, V C ^a   Mendes, J M ^a   Vieira, I F ^b   Arabe, J ^c   Gomes, S A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Hosp Esc Sao Francisco A   (Brazil)

^c HOSPITAL UNIVERSITÁRIO GAFFRÉE E GUINLE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

EID: 0037300849     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-002-0868-0     Document Type: Article

References (49)

1. Medrano FJ, Sanchez-Quijano A, Pineda J, Lissen E (1991) Isolated anti-HBc and hepatitis B virus occult infection. Vox Sang 61:140
2. Coursaget P, LeCann P, Leboulleux D, Diop MT, Bao O, Coll AM (1991) Detection of hepatitis B virus DNA by polymerase chain reaction in HBsAg negative Senegalense patients suffering from cirrhosis or primary liver cancer. FEMS Microbiol Lett 67:35-39
3. Elghouzzi MH, Couroucé AM, Magnius LO, Lunel F, Lapierre V (1995) Transmission of hepatitis B virus by HBV-negative blood transfusion. Lancet 346:964
4. Gomes SA, Yoshida CF, Niel C (1996) Detection of hepatitis B virus DNA in hepatitis B surface antigen-negative serum by polymerase chain reaction: evaluation of different primer pairs and conditions. Acta Virol 40:133-138
5. Hoofnagle JH, Seef LB, Bales ZB, Zimmerman HJ (1978) Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 298:1379-1383
6. Iizuka H, Ohmura K, Ishijima K, Satoh T, Tanaka F, Tsuda H, Okamoto Y, Miyakawa Y, Mayumi M (1992) Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 63:107-111
7. Luo KX, Zhou R, He C, Liang ZS, Jiang SB (1991) Hepatitis B virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis B core antigen. J Med Virol 35:55-59
8. Loriot MA, Marcellin P, Bismuth E, Martinot-Peignoux M, Boyer N, Degott C, Erlinger S, Benhamou JP (1992) Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology 15:32-36
9. Luo KX, Zhou R, Liang ZS, Jiang S (1992) Correlation between the prevalence of serum HBV DNA and immunoserologic HBV markers in the subjects with or without hepatitis. Immunol Invest 21:275-281
10. Thiers V, Nakajima E, Kremsdorf D, Mack D, Schellekens H, Driss F, Goudeau A, Wands J, Sninsky J, Tiollais P, Brechot C (1988) Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet ii:1273-1276
11. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P (2001) Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology 34:194-203
12. Conjeevaram HS, Lok AS (2001) Occult hepatitis B virus infection: a hidden menace? Hepatology 34:204-206
13. Pastore G, Santantonio T, Monno L, Milella M, Luchena N, Angarano G (1988) Effects of HIV superinfection on HBV replication in a chronic HBsAg carrier with liver disease. J Hepatol 2:164-168
14. Gilson RJ, Tedder RS, Weller IV (1989) Hepatitis B: reactivation or reinfection associated with HIV-1 infection. Lancet ii:1330
15. Vento S, di Perri G, Luzzati R, Cruciani M, Garofano T, Mengoli C, Concia E, Bassetti D (1989) Clinical reactivation of hepatitis B in anti-HBs-positive patients with AIDS. Lancet i:332
16. Hino K, Basuni AA, Ireland J, Newell A, Mphahlele J, Smit EJ, Ngui SL, Teo CG, Carman WF (2002) Reappearance of hepatitis B surface antigen in immunocompromised individuals: reinfection or reactivation? Dig Dis Sci 47:415-418
17. Hofer M, Joller-Jemelka HI, Grob PJ, Luthy R, Opravil M (1998) Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Eur J Clin Microbiol Infect Dis 17:6-13
18. Sanchez-Quijano A, Jauregui JI, Leal M, Pineda JA, Castilla A, Abad MA, Civeira MP, de Pesquera FG, Prieto J, Lissen E (1993) Hepatitis B virus occult infection in subjects with persistent isolated anti-HBc reactivity. J Hepatol 3:288-293
19. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H (2001) Hepatitis B virus markers in anti-HBc only positive individuals. J Med Virol 64:312-319
20. Carman WF (1997) The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4:11-20
21. Zuckerman AJ (2000) Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 355:1382-1384
22. Benhamou Y, Dohin E, Lunel-Fabiani F, Poynard T, Huraux JM, Katlama C, Opolon P, Gentilini M (1995) Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients. Lancet 345:396-397
23. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M (1995) A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333:1657-1661
24. Bessesen M, Ives D, Condreay L, Lawrence S, Sherman KE (1999) Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine. Clin Infect Dis 5:1032-1035
25. Lai CL, Yuen MF (2000) Profound suppression of hepatitis B virus replication with lamivudine. J Med Virol 61:367-373
26. Honkoop P, de Man RA, Zondervan PE, Schalm SW (1997) Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine. Liver 17:103-106
27. Dore GJ, Cooper DA, Barrett C, Goh LE, Thakrar B, Atkins M (1999) Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). J Infect Dis 180:607-613
28. Hoff J, Bani-Sadr F, Gassin M, Raffi F (2001) Evaluation of chronic hepatitis B virus (HBV) infection in coinfected patients receiving lamivudine as a component of anti-human immunodeficiency virus regimens. Clin Infect Dis 32:963-969
29. Thibault V, Benhamou Y, Seguret C, Bochet M, Katlama C, Bricaire F, Opolon P, Poynard T, Agut H (1999) Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus. J Clin Microbiol 37:3013-3016
30. Niel C, Moraes MT, Gaspar AMC, Yoshida CF, Gomes AS (1994) Genetic diversity of hepatitis B virus strains isolated in Rio de Janeiro, Brazil. J Med Virol 44:180-186
31. Enzensberger R, Braun W, July C, Helm EB, Doerr HW (1991) Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection. Infection 19:140-145
32. Saillour F, Dabis F, Dupon M, Lacoste D, Trimoulet P, Rispal P, Monlun E, Ragnaud JM, Morlat P, Pellegrin JL, Fleury H, Couzigou P (1996) Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus infection in patients with HIV infection in Aquitaine. BMJ 313:461-464
33. Mendes-Correa MC, Barone AA, Cavalheiro N, Tengan FM, Guastini C (2000) Prevalence of hepatitis B and C in the sera of patients with HIV infection in São Paulo, Brazil. Rev Inst Med Trop Sao Paulo 42:81-85
34. Oliveira LH, Silva IR, Xavier BL, Cavalcanti SM (2001) Hepatitis B infection among patients attending a sexually transmitted diseases clinic in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 96:635-640
35. Treitinger A, Spada C, Silva EL, Miranda AF, Oliveira OV, Silveira MV, Verdi JC, Abdalla DS (1999) Prevalence of serologic markers of HBV and HCV infection in HIV-1 seropositive patients in Florianopolis, Brazil. Braz J Infect Dis 3:1-5
36. Treitinger A, Spada C, Ferreira LA, Neto MS, Reis M, Verdi JC, de Miranda AF, de Oliveira OV, Van der Sander Silveira M, Abdalla DS (2000) Hepatitis B and hepatitis C prevalence among blood donors and HIV-1-infected patients in Florianopolis, Brazil. Braz J Infect Dis 4:192-196
37. Santos EA, Niel C, Vianna CO, de Sa CA, Gomes AS (1998) Genomic variations of hepatitis B virus strains in patients chronically coinfected with hepatitis B and human immunodeficiency viruses. Acta Virol 42:27-33
38. De Castro L, Araujo NM, Sabino RR, Alvarenga F, Yoshida CF, Gomes AS (2000) Nosocomial spread of hepatitis B virus in two hemodialysis units, investigated by restriction fragment length polymorphism analysis. Eur J Clin Microbiol Infect Dis 19:531-537
39. Bréchot C, Hadchouel M, Scotto J, Fonck M, Potet F, Vyas GN, Tiollais P (1981) State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and negative liver diseases. Proc Natl Acad Sci USA 78:3906-3910
40. Lai MY, Chen PJ, Yang PM, Sheu JC, Sung JL, Chen DS (1990) Identifcation and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology 12:575-581
41. Mason AL, Xu L, Guo L, Kuhns M, Perrillo RP (1998) Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen. Hepatology 27:1736-1742
42. Owiredu WK, Kramvis A, Kew MC (2001) Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D. J Med Virol 64:441-454
43. Ackerman Z, Wands JR, Gazitt Y, Bréchot C, Kew MC, Shouval D (1994) Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J Hepatol 20:398-404
44. Liang TJ, Blum HE, Wands JR (1990) Characterization and biological properties of a hepatitis B virus isolated from a patient without hepatitis B virus serologic markers. Hepatology 12:204-212
45. Nevens F, Main J, Honkoop P, Tyrrell DL, Barber J, Sullivan MT, Fevery J, De Man RA, Thomas HC (1997) Landvudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology 113:1258-1263
46. Benhamou Y, Katlama C, Lunel F, Coutellier A, Dohin E, Hamm N, Tubiana R, Herson S, Poynard T, Opolon P (1996) Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 125:705-712
47. Wolters LM, Niesters HG, Hansen BE, van der Ende ME, Kroon FP, Richter C, Brinkman K, Meenhorst PL, de Man RA (2002) Development of hepatitis B virus resistance for lamivudine in chronic hepatitis B patients co-infected with the human immunodeficiency virus in a Dutch cohort. J Clin Virol 24:173-181
48. Thibault V, Benhamou Y, Seguret C, Bochet M, Katlama C, Bricaire F, Opolon P, Poynard T, Agut H (1999) Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus. J Clin Microbiol 37:3013-3016
49. Lai CL, Yuen MF (2000) Profound suppression of hepatitis B virus replication with lamivudine. J Med Virol 61:367-373